Anixa Biosciences, Inc.
ANIX
$2.79
$0.176.49%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.82% | 19.44% | 6.52% | 31.10% | 11.12% |
| Total Depreciation and Amortization | 11.11% | 11.11% | 0.00% | 200.00% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.21% | 6.33% | -14.37% | -33.76% | -6.64% |
| Change in Net Operating Assets | -31.43% | -74.55% | -38.64% | 86.49% | -69.03% |
| Cash from Operations | -15.83% | 10.12% | -35.38% | 42.83% | -3.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.98% | -54.57% | -24.57% | -130.58% | 321.22% |
| Cash from Investing | -81.98% | -54.57% | -24.57% | -130.58% | 321.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 71,750.00% | -- | -- | 612.50% | -99.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9,658.82% | 9,658.82% | -87.05% | 11.51% | 100.77% |
| Cash from Financing | 6,838.89% | 10,011.76% | 230.19% | 1,194.63% | -97.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.17% | 238.99% | -645.65% | -280.43% | 28,666.67% |